These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Chemoprevention of prostate cancer. Stephenson AJ; Abouassaly R; Klein EA Urol Clin North Am; 2010 Feb; 37(1):11-21, Table of Contents. PubMed ID: 20152515 [TBL] [Abstract][Full Text] [Related]
9. Selenium and prostate cancer prevention. Nelson MA; Porterfield BW; Jacobs ET; Clark LC Semin Urol Oncol; 1999 May; 17(2):91-6. PubMed ID: 10332922 [TBL] [Abstract][Full Text] [Related]
10. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice. Lim LS; Sherin K; Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648 [TBL] [Abstract][Full Text] [Related]
11. Update on prostate cancer chemoprevention. Lowe JF; Frazee LA Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715 [TBL] [Abstract][Full Text] [Related]
12. SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design. Klein EA; Thompson IM; Lippman SM; Goodman PJ; Albanes D; Taylor PR; Coltman C Prostate Cancer Prostatic Dis; 2000 Nov; 3(3):145-151. PubMed ID: 12497090 [TBL] [Abstract][Full Text] [Related]
13. Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. Kramer BS; Hagerty KL; Justman S; Somerfield MR; Albertsen PC; Blot WJ; Carter HB; Costantino JP; Epstein JI; Godley PA; Harris RP; Wilt TJ; Wittes J; Zon R; Schellhammer P; J Urol; 2009 Apr; 181(4):1642-57. PubMed ID: 19249063 [TBL] [Abstract][Full Text] [Related]
14. Screening for prostate cancer: opportunities for prevention. Thompson IM; Coltman CA Semin Urol Oncol; 1996 May; 14(2 Suppl 2):4-10; discussion 10-1. PubMed ID: 8725886 [TBL] [Abstract][Full Text] [Related]
15. Can prostate cancer be prevented? Klein EA Nat Clin Pract Urol; 2005 Jan; 2(1):24-31. PubMed ID: 16474573 [TBL] [Abstract][Full Text] [Related]
16. Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention? Moyad MA; Carroll PR Urol Clin North Am; 2004 May; 31(2):301-11. PubMed ID: 15123409 [TBL] [Abstract][Full Text] [Related]
17. Minority issues in prostate disease. French DB; Jones LA Med Clin North Am; 2005 Jul; 89(4):805-16. PubMed ID: 15925651 [TBL] [Abstract][Full Text] [Related]
18. Should prostate-specific antigen screening be offered to asymptomatic men? van Vugt HA; Bangma CH; Roobol MJ Expert Rev Anticancer Ther; 2010 Jul; 10(7):1043-53. PubMed ID: 20645694 [TBL] [Abstract][Full Text] [Related]
19. [Adenocarcinoma of the prostate]. Dvorácek J Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503 [TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of prostate cancer: agents and study designs. Thompson IM J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]